IDHQ - ETF AI Analysis

Top Page

Invesco S&P International Developed High Quality ETF (IDHQ)

Rating:65Neutral

Price Target:―

The overall rating of the Invesco S&P International Developed High Quality ETF (IDHQ) reflects a mix of strong and moderate-performing holdings. Novartis AG stands out as a key contributor, supported by its robust profitability, stable balance sheet, and growth in key products, which enhance the fund's quality. However, holdings like Airbus Group SE and Rolls-Royce Holdings have faced challenges such as bearish momentum and financial stability concerns, slightly tempering the ETF's rating. A notable risk factor is the fund's exposure to companies with high valuation metrics, which could impact future performance.

Positive Factors

Strong Top Holdings

Several of the ETF’s largest positions, such as ASML Holding NV and Nestlé SA, have delivered strong year-to-date performance, supporting overall returns.

Global Diversification

The ETF has exposure to multiple countries, including the UK, Switzerland, Japan, and Australia, reducing reliance on any single market.

Low Expense Ratio

With an expense ratio of 0.29%, the ETF offers a cost-effective way to invest in high-quality international stocks.

Negative Factors

Underperforming Holdings

Some top holdings, like LVMH Moet Hennessy Louis Vuitton, have shown weak year-to-date performance, which could drag on overall returns.

Sector Concentration

The ETF has significant exposure to Health Care, Financials, and Industrials, which may increase risk if these sectors face challenges.

Limited U.S. Exposure

With only 5.94% of assets in U.S. companies, the ETF may miss opportunities in the world’s largest economy.

IDHQ vs. SPDR S&P 500 ETF (SPY)

AUM601.22M

RegionDeveloped Markets

Expense Ratio0.29%

Beta0.71

IssuerInvesco

Inception DateJun 13, 2007

Dividend Yield2.35%

Asset ClassEquity

Index TrackedS&P Quality Developed Ex-U.S. LargeMidCap Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume60,809

30 Day Avg. Volume55,711

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

38.93

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering177

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IDHQ Summary

The Invesco S&P International Developed High Quality ETF (IDHQ) is an investment fund that focuses on high-quality companies in developed markets outside the U.S. It follows the S&P Quality Developed Ex-U.S. LargeMidCap Index, which selects companies with strong financial health, stable earnings, and efficient operations. Some well-known companies in this ETF include Nestlé and ASML Holding. Investors might consider IDHQ to diversify their portfolio internationally and gain exposure to reliable, top-tier global businesses. However, since it invests in international markets, its performance can be affected by currency fluctuations and economic conditions in other countries.

How much will it cost me?The Invesco S&P International Developed High Quality ETF (IDHQ) has an expense ratio of 0.29%, which means you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specialized strategy of selecting high-quality international companies. The added cost reflects the fund's meticulous approach to targeting financially strong firms.

What would affect this ETF?Positive drivers for IDHQ include potential growth in developed markets outside the U.S., particularly in sectors like healthcare and technology, which are heavily weighted in the ETF and often benefit from innovation and stable demand. However, negative factors could arise from global economic slowdowns, regulatory changes in key regions, or currency fluctuations that impact international companies' profitability. The ETF's focus on high-quality companies may help mitigate risks but does not eliminate exposure to broader market challenges.

IDHQ Top 10 Holdings

The IDHQ ETF is leaning heavily on high-quality international names, with a clear focus on developed markets outside the U.S. Health care giants like Roche and Novartis are rising stars, buoyed by strong pipelines and steady earnings growth, while Nestlé and AstraZeneca provide stability despite mixed momentum. ASML Holding, a leader in technology, continues to drive performance with robust growth, but Unilever is lagging, weighed down by bearish sentiment and weak recent results. Overall, the fund’s sector mix is balanced, with health care and financials leading the charge, offering resilience and growth potential.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	5.38%	$32.09M	€414.15B	52.06%	76 Outperform
ROG	Roche Holding AG	4.30%	$25.69M	CHF275.00B	44.94%	73 Outperform
NOVN	Novartis AG	4.14%	$24.73M	CHF220.89B	28.13%	80 Outperform
6857	Advantest	3.14%	$18.73M	¥16.87T	144.96%	75 Outperform
RR	Rolls-Royce Holdings	2.99%	$17.86M	£107.08B	146.81%	71 Outperform
SAF	SAFRAN SA	2.87%	$17.14M	€131.75B	43.90%	67 Neutral
ALV	Allianz	2.65%	$15.79M	€143.49B	27.01%	67 Neutral
ULVR	Unilever	2.40%	$14.30M	£105.36B	-3.79%	72 Outperform
EADSF	Airbus Group SE	2.37%	$14.14M	$198.48B	55.55%	68 Neutral
6501	Hitachi,Ltd.	2.22%	$13.26M	¥24.66T	40.65%	77 Outperform

IDHQ Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

34.84

Positive

100DMA

34.20

Positive

200DMA

32.79

Positive

Market Momentum

MACD

0.60

Negative

RSI

70.15

Negative

STOCH

90.29

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDHQ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.72, equal to the 50-day MA of 34.84, and equal to the 200-day MA of 32.79, indicating a bullish trend. The MACD of 0.60 indicates Negative momentum. The RSI at 70.15 is Negative, neither overbought nor oversold. The STOCH value of 90.29 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IDHQ.

IDHQ Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IDHQ	―	―	$601.22M	0.29%	―
DFSI	―	―	$963.46M	0.24%	―
SEIE	―	―	$894.51M	0.50%	―
IMFL	―	―	$692.34M	0.34%	―
TLTD	―	―	$606.57M	0.39%	―
FYLD	―	―	$503.96M	0.59%	―

Performance Comparison

IDHQ

Invesco S&P International Developed High Quality ETF

36.81

8.83

31.56%

DFSI

Dimensional International Sustainability Core 1 ETF

―

SEIE

SEI Select International Equity ETF

―

IMFL

Invesco International Developed Dynamic Multifactor ETF

―

TLTD

FlexShares Morningstar Developed Markets ex-US Factor Tilt

―

FYLD

Cambria Foreign Shareholder Yield ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents